Algert Global LLC acquired a new stake in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 110,710 shares of the company's stock, valued at approximately $2,825,000. Algert Global LLC owned approximately 0.25% of Azenta at the end of the most recent quarter.
Several other hedge funds also recently made changes to their positions in the business. BlackRock Inc. acquired a new stake in shares of Azenta during the 2nd quarter valued at $192,152,000. Vanguard Group Inc. boosted its stake in shares of Azenta by 2.2% during the 4th quarter. Vanguard Group Inc. now owns 4,538,946 shares of the company's stock worth $150,965,000 after acquiring an additional 99,588 shares in the last quarter. Conestoga Capital Advisors LLC grew its holdings in shares of Azenta by 116.1% in the 1st quarter. Conestoga Capital Advisors LLC now owns 2,844,546 shares of the company's stock worth $60,105,000 after acquiring an additional 1,528,145 shares during the last quarter. Millennium Management LLC raised its position in shares of Azenta by 9.9% during the fourth quarter. Millennium Management LLC now owns 1,866,531 shares of the company's stock worth $62,081,000 after purchasing an additional 167,969 shares during the period. Finally, State Street Corp raised its position in shares of Azenta by 1.4% during the fourth quarter. State Street Corp now owns 1,732,755 shares of the company's stock worth $57,631,000 after purchasing an additional 24,062 shares during the period. Institutional investors and hedge funds own 99.08% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities analysts recently weighed in on AZTA shares. Weiss Ratings raised Azenta from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Wednesday. Needham & Company LLC upped their price objective on shares of Azenta from $33.00 to $37.00 and gave the company a "buy" rating in a research note on Wednesday, August 5th. Four analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $41.20.
Get Our Latest Report on AZTA
Azenta Stock Performance
NASDAQ:AZTA opened at $32.95 on Friday. The firm's 50-day moving average is $28.93 and its 200-day moving average is $25.20. The company has a market cap of $1.44 billion, a price-to-earnings ratio of -11.94 and a beta of 1.37. Azenta, Inc. has a 52-week low of $15.93 and a 52-week high of $41.73.
Azenta (NASDAQ:AZTA - Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $0.16 earnings per share for the quarter, topping analysts' consensus estimates of $0.11 by $0.05. The business had revenue of $161.18 million for the quarter, compared to the consensus estimate of $149.31 million. Azenta had a positive return on equity of 1.18% and a negative net margin of 20.63%.
Azenta Profile
(
Free Report)
Azenta, Inc NASDAQ: AZTA is a life sciences technology company specializing in sample management, cryogenic storage and genomic services for research and clinical applications. Formerly the Life Sciences division of Brooks Automation, Azenta provides integrated solutions that enable customers to store, track and analyze biological samples with high levels of automation, data integrity and efficiency. Its offerings span automated storage systems, biorepository management software and end‐to‐end sample tracking workflows.
In addition to hardware and informatics platforms for sample storage, Azenta's Genomics business delivers next‐generation sequencing (NGS), DNA synthesis, and molecular biology services.
Read More
Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
